Quick Picks - Cyberonics Inc. (NASDAQ:CYBX) today released Fiscal 1Q 2013 results that beat analyst expectations, sending shares up 10% in early trading, only to decline slightly into … Continue Reading
Read nowLong Ideas - Amarin Pharmaceuticals (NASDAQ:AMRN) could trade higher as investors digest this morning’s news that Roche’s (OTC:RHHBY) former Head of Global Pharmaceuticals has joined AstraZeneca (NYSE:AZN) as … Continue Reading
Read nowLong Ideas - Catalyst Pharmaceutical Partners (NASDAQ:CPRX) announced that in a direct public offering of 4 million shares of common stock and 1.2MM warrants, it will be raising … Continue Reading
Read now- Peregrine Pharmaceuticals (NASDAQ:PPHM) is becoming known among biotech traders for the company’s big swings and volatility. This morning’s 19% decline can be attributed to a … Continue Reading
Read now- After receiving word from the FDA that lead hepatitis C (HCV) treatment candidate, IDX-184, was placed on partial clinical hold as of mid-August, Idenix Pharmaceuticals … Continue Reading
Read nowQuick Picks - Genzyme, a subsidiary of Sanofi (NYSE:SNY), announced this morning that the FDA has returned the company’s supplemental Biologics License Application (sBLA) for Lemtrada on grounds … Continue Reading
Read now- Immunogen’s (NASDAQ: IMGN) partner, Roche Holdings (OTC:RHHBY), reported new data from a Phase III trial, demonstrating that trastuzumab emtansine (T-DM1), which leverages technology from IMGN, … Continue Reading
Read now